We recently compiled a list of the 15 Best Cheap Stocks to Buy for 2025. In this article, we are going to take a look at ...

Louis Navellier is a prominent American investor, author, and financial analyst, best known for his quantitative approach to ...

Friday announced that the U.S. Food and Drug Administration has approved its Lumakras plus Vectibix combination ...

Amgen Inc (AMGN) stock saw a modest uptick, ending the day at $268.94 which represents a slight increase of $1.84 or 0.69% from the prior close of $267.1. The stock opened at $269.33 and touched a low ...

With that in mind, let's consider two stocks that haven't performed well recently and are now near their 52-week lows but that are still worth investing in: CRISPR Therapeutics (NASDAQ: CRSP) and ...

Jefferies analyst Michael Yee maintained a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $350.00. The company’s ...

Amgen Inc. closed $79.75 short of its 52-week high ($346.85), which the company achieved on July 25th.

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the past ...

Amgen Inc (AMGN) stock saw a modest uptick, ending the day at $270.19 which represents a slight increase of $7.96 or 3.04% from the prior close of $262.23. The stock opened at $262.11 and touched a ...

In a judgment of 23 December 2024, the Dutch-speaking Enterprise Court of Brussels followed the reasoning of a Dutch court earlier in 2024, ...

Harbor Capital Advisors Inc. increased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 2.5% during the ...

Amgen (NASDAQ:AMGN – Get Free Report) had its target price dropped by equities research analysts at Wells Fargo & Company ...